Company profile: Phraxis
1.1 - Company Overview
Company description
- Provider of medical devices enabling vascular access for hemodialysis, including EndoForce, a transcatheter-delivered endovascular anastomotic connector designed for coaxial anastomosis of a vein to an arteriovenous graft, featuring a flexible nitinol segment, a rigid segment for radial force, and nitinol anchoring barbs.
Products and services
- EndoForce™: A custom-engineered, transcatheter-delivered anastomotic connector engineered for coaxial endovascular anastomosis of a vein to an arteriovenous graft, featuring a flexible nitinol segment, a rigid radial-force segment, and nitinol anchoring barbs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Phraxis
MedAlliance
HQ: Switzerland
Website
- Description: Provider of innovative drug-eluting balloons (DEBs) for treating coronary and peripheral arterial disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedAlliance company profile →
Synaptic Medical
HQ: United States
Website
- Description: Provider of medical devices for cryoablation and cardiac procedures, including the Nordica Cryo Console and Nordica Balloon Catheter (both under investigation), a Pulmonary Vein Mapping Catheter, NaviGo 12F and NaviEase intracardiac catheter introducer kits, and the AKS Transseptal Needle for transseptal access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synaptic Medical company profile →
GENinCode
HQ: United Kingdom
Website
- Description: Provider of genetic testing solutions for cardiovascular disease risk assessment and prediction, combining genetic and clinical data to guide patient evaluation. Offerings include CARDIO inCode-Score for coronary heart disease, LIPID inCode for hyperlipidemia and familial hypercholesterolemia, SUDD inCode for sudden cardiac death, THROMBO inCode for venous thromboembolism, ROCA for ovarian cancer, and SITAB web portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GENinCode company profile →
Aria CV
HQ: United States
Website
- Description: Provider of a medical device in development designed to improve the lives of patients living with pulmonary hypertension.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aria CV company profile →
enVVeno Medical
HQ: United States
Website
- Description: Provider of bioprosthetic devices for cardiovascular surgeries, including VenoValve, a surgically implanted one-way valve to restore proper blood flow in the femoral vein for patients with deep venous Chronic Venous Insufficiency (CVI), and enVVe, a non-surgical, transcatheter-based replacement venous valve for minimally invasive treatment of CVI in the deep veins of the leg.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full enVVeno Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Phraxis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Phraxis
2.2 - Growth funds investing in similar companies to Phraxis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Phraxis
4.2 - Public trading comparable groups for Phraxis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →